PHIBRO ANIMAL HEALTH CORP

For the period ended Dec 31, 2025. Filed Feb 4, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Dec 31, 2025 · Filed Feb 4, 2026

PAHC$34.61+5.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Operations


· · Three Months · · Six Months ·
For the Periods Ended December 31 · · 2025 · · 2024 · · 2025 · · 2024 ·
· · (unaudited) ·
· · (in thousands, except per share amounts) ·
Net sales	$373,910	$309,261	$737,803	$569,693
Cost of goods sold	241,254	207,391	485,364	384,328
Gross profit	132,656	101,870	252,439	185,365
Selling, general and administrative expenses	82,330	76,337	150,853	142,133
Operating income	50,326	25,533	101,586	43,232
Interest expense, net	11,756	8,996	23,815	16,637
Foreign currency losses, net	2,145	11,699	5,079	12,137
Income before income taxes	36,425	4,838	72,692	14,458
Provision for income taxes	8,966	1,653	18,706	4,298
Net income	$27,459	$3,185	$53,986	$10,160

Net income per share
basic	$0.68	$0.08	$1.33	$0.25
diluted	$0.67	$0.08	$1.32	$0.25
Weighted average common shares outstanding
basic	40,534	40,504	40,534	40,504
diluted	40,956	40,715	40,916	40,649

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.